|
|
News Breaks | | | | February 6, 2013 | | 08:04 EDT |  | RL | Ralph Lauren reports Q3 EPS $2.31, consensus $2.19
Reports Q3 revenue $1.8B, consensus $1.85B. Reports Q3 SSS up 4%. | |
|
News For RL From The Last 14 Days Check below for free stories on RL the last two weeks. |
|
|
| May 14, 2013 | | 17:48 EDT |  | RL | Lone Pine gives quarterly update on stakes
NEW STAKES: Valeant Pharmaceuticals (VRX), Virgin Media (VMED), Thermo Fisher Scientific (TMO), CME Group (CME), and Liberty Media (LMCA). INCREASED STAKES: Mead Johnson Nutrition (MJN), News Corp (NWSA), Intuitive Surgical (ISRG), Monsanto (MON), and Qualcomm (QCOM). DECREASED STAKES: Cognizant Technology Solutions (CTSH), Equinix (EQIX), Ralph Lauren (RL), Disney (DIS), and Oceaneering International (OII). LIQUIDATED STAKES: Facebook (FB), Crown Castle (CCI), Accretive Health (AH), Informatica (INFA), and NetEase (NTES). | | | 08:06 EDT |  | RL | BofA/Merrill's retail analysts hold an analyst/industry conference call
Global Retail Team discusses key global athletic themes including industry trends, sourcing costs outlook and favorite investment ideas on an Analyst/Industry conference call. Relevant covered companies COLM, COST, DKS, FINL, FL, GES, JNY, NKE, PVH, RL, TGT, UA and WMT may be included on the Analyst/Industry conference call to be held on May 14 at 10 am. | | | May 9, 2013 | | 07:41 EDT |  | RL | Ralph Lauren Q4 results may bring buying opportunity, says Citigroup
Citigroup thinks Ralph Lauren shares could see pressure following the company's Q4 results on May 23 since its investments could weigh on FY14 guidance. Citi lowered its FY14 earnings estimate for Ralph Lauren to $9.10 from $9.40 but says it would use any post-earnings share pullback as a buying opportunity. The firm reiterates a Buy rating on the stock with a $204 price target. | |
|
|
|
|
|
|
